Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Research Solutions (RSSS) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Research Solutions (RSSS) over the last 17 years, with Q3 2025 value amounting to $12.0 million.

  • Research Solutions' Cash & Equivalents rose 7265.21% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.0 million, marking a year-over-year increase of 7265.21%. This contributed to the annual value of $12.2 million for FY2025, which is 10044.67% up from last year.
  • Latest data reveals that Research Solutions reported Cash & Equivalents of $12.0 million as of Q3 2025, which was up 7265.21% from $12.2 million recorded in Q2 2025.
  • In the past 5 years, Research Solutions' Cash & Equivalents ranged from a high of $13.5 million in Q2 2023 and a low of $2.7 million during Q4 2023
  • Its 5-year average for Cash & Equivalents is $9.7 million, with a median of $10.6 million in 2022.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first plummeted by 7604.76% in 2023, then soared by 18547.55% in 2024.
  • Research Solutions' Cash & Equivalents (Quarter) stood at $10.7 million in 2021, then rose by 5.46% to $11.3 million in 2022, then plummeted by 76.05% to $2.7 million in 2023, then skyrocketed by 185.48% to $7.7 million in 2024, then surged by 55.25% to $12.0 million in 2025.
  • Its Cash & Equivalents stands at $12.0 million for Q3 2025, versus $12.2 million for Q2 2025 and $9.9 million for Q1 2025.